# Dan Patrick Highlights THC Regulation in Texas Senate Priorities > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/texas-thc-regulation-policy-senate-priorities/ > **Published:** 2026-03-27T16:05:38-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:36:37-04:00 > **Clinical Summary:** Explore Texas THC regulation policy as Senate priorities shift, impacting medical cannabis patient access and therapeutic options in Texas. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyThcTexasRegulationAccess Why This Matters Political prioritization of THC regulation signals potential policy shifts that could affect patient access to cannabis therapeutics in Texas. Changes in state-level cannabis policy directly impact clinical practice parameters and patient treatment options. Clinical Summary Texas Lieutenant Governor Dan Patrick has identified THC regulation among Senate priorities, though specific policy directions remain undefined. This represents a notable development in a state with historically restrictive cannabis policies. The clinical implications depend entirely on whether proposed changes expand or further restrict therapeutic access to cannabis products containing THC. Dr. Caplan’s Take “Without knowing the specific policy direction, this is essentially a placeholder announcement. What matters clinically is whether Texas will expand access for patients who could benefit from THC-containing therapeutics or create additional barriers.” Clinical Perspective 🧠 Clinicians in Texas should monitor how these priorities translate into actual legislation, particularly regarding [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/) thresholds and qualifying conditions. Patients currently using cannabis therapeutics should stay informed about potential regulatory changes that could affect their treatment continuity. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Dan%20Patrick%20adds%20data%20centers%2C%20prediction%20markets%20and%20THC%20to%20Senate%20priorities%20-...%20%40drcaplan&url=https%3A//www.ksat.com/news/texas/2026/03/27/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.ksat.com/news/texas/2026/03/27/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Dan%20Patrick%20adds%20data%20centers%2C%20prediction%20markets%20and%20THC%20to%20Senate%20priorities%20-...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.ksat.com/news/texas/2026/03/27/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.ksat.com/news/texas/2026/03/27/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/](https://www.ksat.com/news/texas/2026/03/27/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/) Table of Contents - [FAQ](#FAQ)[What type of cannabis policy changes are being discussed in Texas?](#What_type_of_cannabis_policy_changes_are_being_discussed_in_Texas) - [What is the clinical significance of this cannabis news?](#What_is_the_clinical_significance_of_this_cannabis_news) - [How does this relate to medical cannabis patients in Texas?](#How_does_this_relate_to_medical_cannabis_patients_in_Texas) - [What aspects of cannabis regulation are covered in this update?](#What_aspects_of_cannabis_regulation_are_covered_in_this_update) - [Why should healthcare providers pay attention to this news?](#Why_should_healthcare_providers_pay_attention_to_this_news) - [Related](#Related) ## FAQ #### What type of cannabis policy changes are being discussed in Texas? The article appears to focus on THC-related regulatory developments in Texas. However, the full article content was not provided, making specific policy details unavailable. #### What is the clinical significance of this cannabis news? This news has been rated as “Notable Clinical Interest” with a CED Clinical Relevance score of #70. It represents emerging findings or policy developments that healthcare professionals should monitor closely. #### How does this relate to medical cannabis patients in Texas? Any regulatory changes regarding THC policy in Texas could potentially impact [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients’ access to treatment. The clinical relevance rating suggests this development may affect [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions. #### What aspects of cannabis regulation are covered in this update? The article covers policy and regulation topics specifically related to THC in Texas. The focus appears to be on regulatory frameworks that could influence cannabis accessibility and usage. #### Why should healthcare providers pay attention to this news? The CED Clinical Relevance rating indicates this is worth monitoring closely for emerging policy developments. Healthcare providers need to stay informed about regulatory changes that may affect their ability to recommend or prescribe [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Dan Patrick adds data centers, prediction markets and THC to Senate priorities – KSAT”, “url”: “https://www.ksat.com/news/texas/2026/03/27/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/”, “datePublished”: “2026-03-27T18:31:43Z”, “about”: “dan patrick adds data centers prediction”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Dan Patrick adds data centers, prediction markets and THC to Senate priorities – Yahoo Detailed coverage of Dan Patrick's Senate priorities including THC regulation and its potential impact on Texas cannabis policy. Read More [Dan Patrick adds data centers, prediction markets and THC to Senate priorities | KVEO-TV](https://cedclinic.com/texas-senate-cannabis-legislative-priorities-update-2026/) Local news perspective on the inclusion of THC regulation in Texas Senate priorities and implications for medical cannabis access. [Explore Article](https://cedclinic.com/texas-senate-cannabis-legislative-priorities-update-2026/) Patrick sets Senate on data centers, prediction markets and THC – NBC 5 Dallas-Fort Worth NBC 5 Dallas-Fort Worth reports on Senate focus areas including THC regulation, highlighting potential policy shifts in Texas. Learn More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).